Table 3.
Groups | SOD/(U/mL) | GSH/(μg/mL) | MDA/(nmol/mL) | IL-6/(pg/mg) | IL-1β/(pg/mg) | TNF-α/(pg/mg) |
---|---|---|---|---|---|---|
Control | 169.27 ± 23.11 | 15.10 ± 3.33 | 3.22 ± 0.68 | 33.91 ± 24.19 | 30.72 ± 21.91 | 1.21 ± 0.95 |
CCl4 | 130.43 ± 4.57** | 6.35 ± 1.08** | 5.97 ± 0.61** | 149.97 ± 47.99** | 841.56 ± 178.76** | 21.90 ± 0.71** |
N-FBRT1 | 164.13 ± 21.23## | 11.87 ± 3.09## | 3.57 ± 0.79## | 45.24 ± 43.34## | 74.67 ± 37.15## | 1.67 ± 1.14## |
N-FBRT2 | 157.32 ± 5.66# | 9.72 ± 2.04# | 4.10 ± 0.85## | 77.64 ± 59.13# | 117.18 ± 35.43## | 3.45 ± 3.12## |
N-FBRT3 | 143.00 ± 4.81 | 10.13 ± 1.58# | 3.77 ± 0.21## | 38.19 ± 37.47## | 260.10 ± 74.63##Δ | 3.03 ± 1.43## |
N-FBRT4 | 136.27 ± 2.26 | 9.21 ± 1.72 | 3.62 ± 0.45## | 80.53 ± 76.26# | 132.69 ± 52.24## | 2.42 ± 2.08## |
FBRT | 160.50 ± 4.75## | 10.03 ± 2.42# | 3.47 ± 0.33## | 41.05 ± 8.42## | 80.22 ± 36.85## | 1.51 ± 0.37## |
Colchicine | 156.00 ± 13.12## | 9.74 ± 1.37# | 4.00 ± 0.53## | 55.24 ± 20.69## | 51.15 ± 28.39## | 2.73 ± 0.27## |
P < 0.01 vs control group; #P < 0.05, ##P < 0.01 vs CCl4 model group; ΔP < 0.05 vs FBRT group.